Creative Medical Technology Holdings Inc.
12/31/2025 | Press release | Distributed by Public on 12/31/2025 15:06
Proxy Results (Form 8-K)
Item 5.07 Submission of Matters to a Vote of Security Holders.
On December 26, 2025, the Company held a Special Meeting of Stockholders (the "Special Meeting") to consider and vote on a proposal to approve the exercise in full of warrants to purchase an aggregate of 2,790,340 shares of the Company's common stock (the "Warrants"), issued by the Company on October 29, 2025 (the "Proposal"). The Proposal is described in more detail in the definitive proxy statement for the Special Meeting filed with the Securities and Exchange Commission on November 13, 2025. Stockholders holding an aggregate of 1,037,465 shares of common stock, representing 36.4% of the outstanding shares of the Company's common stock as of the record date, and which constituted a quorum, were present in person or represented by proxy at the Special Meeting. The results of the voting for the Proposal, which was approved at the Special Meeting, are presented below.
|
For |
Against |
Abstain |
Broker Non-Votes |
|
618,178(1) |
183,985 |
235,381(1) |
N/A |
(1) In accordance with Nasdaq Listing Rules, 220,500 votes "For" cast by holders of the Warrants have been treated as "Abstain" votes.
Creative Medical Technology Holdings Inc. published this content on December 31, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on December 31, 2025 at 21:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]